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Background. We pooled data from four studies, to establish whether exercise training programs were able to modulate systemic
cytokine levels of tumour necrosis factor-alpha (TNF-alpha) and interleukin-6 (IL-6). A second aim was to establish if diﬀerences
in ExT regimens are related to degree of change in cytokines and peak VO2. Methods. Data from four centres relating to
training protocol, exercise capacity, and cytokine measures (TNF-alpha and IL-6) were pooled for analysis. Results.D a t a
for 106 CHF patients were collated (98 men, age 62±10yrs, wt 79±14Kg). Patients were moderately impaired (peak VO2
16.9±4.4mls/kg/min), with moderate LV systolic dysfunction (EF 30±6.9%), 78% (83) had ischaemic cardiomyopathy. After
ExT, peak VO2 increased 1.4±3.4ml/kg/min (P<. 001), serum TNF-alpha decreased 1.9±8.6pg/ml (P = .02) and IL-6 was
not signiﬁcantly changed (0.5 ± 5.4pg/ml, P = .32) for the whole group. Baseline and post-training peak VO2 changes were not
correlated with change in cytokine levels. Conclusions. Exercise training reduces levels TNF-alpha but not IL-6 in CHF. However,
acrossaheterogenicpatientgroup,changeinpeakVO2 wasnotcorrelatedwithalterationsincytokinelevels.Whilegreaterexercise
volume (hours) was superior in improving peak VO2, no particular characteristic of ExT regimes appeared superior in eﬀecting
change in serum cytokines.
1.Introduction
Inﬂammatory activation with increased serum cytokine
levels has been described by several authors as an important
factor in the progression of the syndrome of chronic heart
failure (CHF) [1–3]. In multifactorial analyses, elevated lev-
els of tumour necrosis factor-(TNF-) alpha and interleukin-
(IL-) 6 have been identiﬁed as prognostic heart failure
markers [4–6]. Cytokines act as catabolic factors involved
in the pathogenesis of muscle wasting and cardiac cachexia
[3, 7], and increased levels of serum TNF-alpha have been
identiﬁed in patients with reduced skeletal muscle cross-
sectional area and peripheral muscle strength [1]. There also
exists a statistical signiﬁcant association between elevated
serum cytokine levels (especially TNF-alpha) and New
York Heart Association (NYHA) functional class as well as
exercise intolerance [2]. Inﬂammatory cytokines may alter
skeletal muscle histology and have a negative impact on
left ventricular remodelling and cardiac contractility [2,
3, 8]. The inﬂammatory response is also associated with
progression of atherosclerosis [9], oxidative stress [10], NO
impairment[11],vasoconstriction,endothelialcellapoptosis
[12], and adverse vascular remodelling [13].
Exercise training has been documented to improve the
inﬂammatory proﬁle in CHF by inhibition of cytokine-
chemokine production, regulation of monocyte activation
andadhesion,inhibitionofinﬂammatorycell-growthsignals
andgrowthfactorproduction,reductionofsolubleapoptosis
signalling molecules [12], and attenuation of monocyte-
endothelial cell adhesive interaction [14]. A study of 277
patients with coronary artery disease reported a signiﬁcant
41% reduction in high-sensitivity C-reactive protein
following exercise training [15]. A recent study of four-
month duration, utilizing combined endurance/resistance2 Cardiology Research and Practice
Table 1: Studies identiﬁed in PUBMED, MEDLINE search.
Study Subjects(Control) Year Cytokines measured %  VO2 Mode of Exercise
Adamapoulos et al.
[23] 12 2001 Soluble adhesion molecules 13 Home bike
Adamopoulos et al.
[12] 24 2002 TNF-alpha, Interleukin-6 15 Home bike
Conraads et al.
[16] 23 (12) 2002 TNF-alpha, Interleukin-6 7.5 Bike and resistance training
Ferraz et al. [21]# 30 (10) 2004 TNF-alpha, Interleukin-6 23 Bike
Gielen et al. [2] 20 (10) 2003
TNF-alpha, Interleukin-1, 6 and
beta
In both serum and skeletal muscle
29 Bike
Karavidas et al.
[24] 16 (8) 2006 TNF-alpha, Interleukin-6, 10 7.5∗ Electrical stimulation
Larsen et al. [22]# 28 2001 TNF-alpha, Interleukin-6,8 8∗ Aerobic endurance training
and home bike
Larsen et al. [25] 25 2008 Plasma Chromogranin A (CgA) 8∗ Aerobic endurance training
and home bike
Laoutaris et al. [26] 38 2007 TNF-alpha, Interleukin-6 12 Low versus high intensity
inspiratory muscle training
LeMaitre et al.
[17]# 46 2004 TNF-alpha, Interleukin-6 3 Bike and electrical
stimulation
Niebauer et al. [27] 18 (9) 2005 TNF-alpha Interleukin-6, e-selectin 11 Bike
Smart [28]# 22 2008 TNF-alpha, Interleukin-6, brain
natriurietic peptide (BNP) 20 Bike
Xu et al. [18] 60 (28) 2002 TNF-alpha Unknown Unknown
∗% change in 6-minute walk distance (Peak VO2 not measured). #Study used in this paper.
training demonstrated reduced TNF-alpha receptor levels
(TNFR1 and TNFR2) and a signiﬁcant (7.5%) increase
in peak VO2 in patients with ischemic cardiomyopathy,
although changes in IL-6 and TNF-alpha were not apparent
[16]. This eﬀect on circulating levels of TNF-alpha receptors
is also reported after 6 weeks of cycle ergometry [17]. In this
study, there were no alterations in IL-6, C-reactive protein
(CRP), or TNF-alpha. In addition, electrical muscle stim-
ulation provided no changes in any of the aforementioned
cytokines. Larsen et al. [8] reported an 11% increase in peak
VO2 following 3 months of endurance training; TNF-alpha
was signiﬁcantly reduced, and this decrease was signiﬁcantly
correlated to the increase in peak VO2.A d a m o p o u l o s[ 14]
reported a 13% increase in functional capacity with a
12-week cycle ergometry training program, which correlated
with lower levels of soluble adhesion molecules. The authors
later reported a strong and highly signiﬁcant correlation
between improvements in peak VO2 (15%) and reduction in
TNF-alpha, soluble TNFR-1 and -2, and IL-6 [12]. Plasma
TNF-alphaisalsodocumentedtodecreaseaftertwicedaily6-
minute walk tests in NYHA II/III heart failure patients [18].
A recently published study reported absent von Willebrand
factor (vWF) release upon exercise testing in heart failure
patients; this normalised following 6 months of exercise
training; other plasma endothelial markers were unaltered
[19].
Changes in skeletal muscle, but not systemic expression
of TNF-alpha, IL-1-beta, and IL-6 have been reported in
heart failure patients undertaking a regimen of 10 minutes
cycling, 4–6 times daily for 6 months [2]. This exercise
p r o g r a mr e s u l t e di nl a r g ec h a n g e si nf u n c t i o n a lc a p a c i t y
(29%), nearly twice the mean expected increment (17%)
shown from our review of 81 heart failure exercise training
studies [20]. This study suggested the existence of a cytokine
cascade where levels may be changed at altered rates in
diﬀerent tissues. As heart failure exercise training studies are
often small, we sought by pooling data from four studies
to establish whether exercise training programs were able
to modulate systemic cytokine levels. A second aim was to
establish if diﬀerences in ExT regimens are related to the
degree of change in cytokines and peak VO2.
2. Methods
We searched PUBMED and MEDLINE for exercise training
studies in heart failure patients that had measured one or
more of the proinﬂammatory cytokines. The full list of
studies is summarized in Table 1. The focus of this work
was interleukin-6 and TNF-alpha as these cytokines were
measured in 10 exercise training studies, the correspondence
authors of which were contacted for their cooperation in
collaboration. Authors were requested to provide individual
patient data from their study; four centres provided data
(Table 2). One study was a conference proceedings abstract
[21]. Suﬃcient data were not available to analyse changes in
other cytokines.Cardiology Research and Practice 3
Table 2: Clinical characteristics and pharmacotherapy of the 106
patients.
Clinical characteristics
Age (Years) 61.8±9.9
Male (%) 98 (92.5)
Body mass (kg) 78.7±13.7
Peak VO2 (ml·kg−1·min−1) 16.9±4.4
Diabetes (%) 11 (10)
Previous myocardial infarction (%) 86 (81)
Atrial ﬁbrillation (%) 27 (26)
NYHA class II/III 49/57
LVEF (%) 30 ±6.9
Medications
Beta-blocker (%) 44 (42)
ACE-inhibitor/antagonist (%) 95 (90)
Digoxin (%) 67 (63)
Nitrates (%) 40 (38)
2.1. Blood Sampling and Analysis. In 3 studies, plasma or
serum samples were obtained by venipuncture (arterial
cannula used in Larsen’s study) and stored on ice. In
all studies, venipuncture collections were taken between
0900, and 1200, at least 24 hours and not more than
5 days after the last exercise session, thus negating the
eﬀects of the intervention. Within one hour, samples were
centrifugedat4◦C,1500–2000RPMfor10minutes,andthen
separated into aliquots and stored at between −75◦Ca n d
−80◦C. Concentrations of IL-6 or TNF-alpha were measured
by commercially available enzyme-linked immunosorbent
assays (ELISAs) (R&D systems Minneapolis, Minnesota)
in all 4 studies. The intra- and interassay coeﬃcients of
variation were <10% for all assays. In one study, 16 healthy,
male volunteers of approximately the same age (62±5y e a r s )
served as controls [22] although this data was not included
in our analyses.
2.2. Metabolic Exercise Testing and Exercise Training. All
four collaborating investigators completed baseline and
posttraining metabolic exercise tests to establish functional
capacity.
Larsen and Smart used cycle ergometers with a 15W and
10W per min stepped protocol, respectively; LeMaitre and
Ferraz used a modiﬁed Bruce treadmill protocol.
One study used a regime of supervised aerobic exercise
training 3 times per week. Two studies used supervised cycle
ergometry as the primary mode of exercise training [21, 22],
and one study used both home-based and neuromuscular
stimulation of the legs [17].
2.3. Data Extraction. Mode of training, program duration
and exercise intensity were examined. Baseline and post-
training cytokine levels, peak VO2,l e f tv e n t r i c u l a re j e c t i o n
fraction(LVEF),clinical,demographic,andpharmacological
characteristics of patients are shown in Table 2.
Table 3: Exercise program parameters and change in primary
outcome measures in the 4 studies.
Ferraz Larsen LeMaitre Smart
Weeks 24 12 6 16
Minutes/Wk 135 90 150 90
Freq. sessions/Wk 3 3 5 3
Intensity (% max) 67 80 70 70
Total hours 54 54 15 48
2.4. Statistical Analysis. Paired student t-tests were used to
analyse baseline and postintervention changes in cytokines
and peak VO2.A N O V A( 2× 4) was used to analyse
diﬀerences between the four datasets. Pearson correlation
coeﬃcientswereestablishedforchangeincytokinesandpeak
VO2. Univariate and multivariate regression analysis with
change in TNF-alpha as the dependent variable were used
to determine factors leading to cytokine change. Data are
expressed as mean +/− standard deviation unless otherwise
stated. Signiﬁcance was accepted at the 5% level (P<. 05).
3. Results
3.1. Baseline Measures. The four collaborating authors pro-
vided data on 106 patients (98 male, age 62±10yrs, body
weight 79±14Kg).Patientsweremoderatelyimpaired(peak
VO2 16.9±4.4mls/kg/min), with moderate LV systolic dys-
function (EF 30±6.9%). Seventy eight % (83) had an
ischaemiccardiomyopathy(Table 2).Adherencedatarelating
to training regimes were 87.2±1.9% [21]a n d8 5±12% [28]
and were unavailable for the other 2 studies.
3.2. Training Regimes. Regimes varied between 3 and 5
exercise sessions per week, at an intensity of 58–80% of
peak VO2. Program durations were between 6 and 24 weeks,
90–150 minutes per week, and total program hours varied
between 15 and 54 hours (Table 3).
3.3. Pooled Posttraining Changes. After training, peak VO2
increased by 1.4±3.4mL/kg/min or 9% (P<. 001) from
16.9±4.4 to 18.4±4.5, serum TNF-alpha decreased from a
baseline value of 13±15.2pg/mL by 1.9±8.6pg/mL (P =
.02), and IL-6 increased slightly from a baseline value of
7.8±11.4pg/mL by 0.5±5.4pg/mL (P = .32). Cytokine
changes for each study can be seen in Figure 1.B o d y
weight was unchanged following exercise training. None
of the clinical, demographic, or pharmacologic variables
were correlated with changes in circulating IL-6 or TNF-
alpha following training. The correlations between change in
posttrainingpeakVO2 andchangesinTNF-alpha(r = 0.023,
P = .82) and IL-6 (r =− 0.12, P = .21) were not signiﬁcant.
Change in TNF-alpha was correlated with exercise session
duration and anerobic threshold (both r = 0.21, P =
.31), univariate but not multivariate analysis identiﬁed
that previous myocardial infarction, longer exercise session
duration, and higher body mass index predicted change in
TNF-alpha (r2 = 0.18, P = .001).4 Cardiology Research and Practice
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Figure1:ChangeincytokinesandpeakVO2 acrossthefourstudies.
3.4. Optimal Exercise Program Components for Peak VO2
and Cytokine Changes. A total exercise program duration
o f5 4h o u r sa p p e a r e dt ob es u p e r i o rt h a n1 5o r1 8h o u r s
in eﬀecting change in peak VO2 (P<. 001); however,
no diﬀerence was seen for change in cytokine levels. The
longest program duration resulted in a greater increment in
peak VO2 compared to 12 weeks (P = .003) and 6 weeks
(P = .001), while peak VO2 or 6-minute walk distance was
unchanged in the ExT programs of 6 and 12 weeks duration.
4. Discussion
Pooled data from four studies demonstrated that alterations
in levels of the cytokines IL-6 and TNF-alpha are not nec-
essarily uniform. Increments in peak VO2 following exercise
training are widely accepted; however, they may be unrelated
tochangesincytokinelevels.Moreover,changesinparticular
cytokinesappeartobeindependentofoneanother.Onecan-
notbesureaboutthevariableeﬀectsofthediﬀerentprogram
parameters and exercise adherence rates; nevertheless, the
mean change in functional capacity from the four studies
was 8%, suggesting that cumulatively the four exercise
programs provided stimulus fora possible favourable change
in cytokine expression. Interpretation of this pooled data
is limited by the fact that several other centres did not
supply data. Table 2 suggests that study participants showed
heterogeneity for age, peak, VO2 and beta-blocker use.
4.1. Expectations of Favourable Changes in Cytokine Expres-
sion. Moderate endurance activity in frail, elderly, but
otherwise healthy persons has previously been reported to
inﬂuence circulating cytokine levels [29]. As our patients
had mild to moderate heart failure, it is not surprising to
observe that levels of systemic TNF-alpha were decreased
after training, thereby initiating anti-inﬂammatory eﬀects.
The ﬁnding that IL-6 was unchanged after training is
more puzzling. However, one study has suggested that
IL-6 produced by exercising muscle is thought to exert
an anti-inﬂammatory eﬀect [30]. These data suggest that
production and removal of TNF-alpha and IL-6 may be, at
least partially, from independent mechanisms and may have
opposing eﬀects (inﬂammatory versus anti-inﬂammatory).
Recent clinical trials have not shown beneﬁt from treatments
that target TNF-alpha. A clinical trial of etanercept (a TNF-
alpha antagonist) therapy has cast doubt on the role of
cytokines in the pathogenesis of heart failure [31]. There are
then implications for health professionals or researchers in
the process of designing an exercise program for heart failure
patients. Primary end points of CHF exercise programs
should perhaps not include lowering cytokine levels as they
may represent surrogate markers of eﬃcacy; this may be
particularly true in patients with milder degrees of CHF. In
this population, program design may be better focussed on
the parameters such as program frequency (sessions/week),
duration (number of weeks), and intensity that may have a
greater eﬀect on peak VO2 changes. Peak VO2 improvement
from exercise training may be linked to attenuated levels
of oxidative stress which in turn may attenuate cytokine
expression. Previous work in healthy older adults [32]a n d
heart failure patients [33] has shown intermittent exercise
programs to be at least more eﬀective in improving peak
VO2 than a continuous regime that would produce greater
cumulative oxidative stress. In our work, peak VO2 was
not signiﬁcantly changed in patients who exercised despite
utilizing a reasonable volume of exercise to elicit functional
capacity changes.
In heart failure, the eﬀect of inﬂammation, which may be
due partly to inactivity, may manifest in the terminal disease
phase. The study by Adamopoulos et al. [14]m a yp r o v i d e
the best evidence to date linking change in peak VO2 and
cytokinesinheartfailurepatients.Thesmallcytokinechange
shown in our studies may be due to the fact that our patients
exhibited mild to moderate heart failure symptoms. The par-
ticipants in the study of Adamopoulos et al. [14] exhibited
moderate to severe symptoms. In addition, our participants
had higher left ventricular ejection fractions (30% versus
24%) than those of Adamopoulos et al. [14]. Exercise train-
ing has been shown to signiﬁcantly reduce the local muscle
expression of TNF-alpha, IL-1-beta, IL-6, and iNOS in the
skeletal muscle of CHF patients [8]. In turn, physical exercise
has been shown to improve both basal endothelial nitric
oxide (NO) formation and agonist-mediated endothelium-
dependent vasodilation of the skeletal muscle vasculature
in patients with CHF. The correction of endothelium
dysfunction is associated with a signiﬁcant increase in
exercise capacity [34]. These local anti-inﬂammatory and
systemic eﬀects of exercise may attenuate the catabolic
wasting process associated with CHF progression [3]. In
addition to an overall beneﬁcial eﬀect on exercise capacity,
combinedendurance/resistanceexercisetraininghasananti-
inﬂammatoryeﬀectinpatientswithheartdisease[16].These
skeletal muscle and anti-inﬂammatory changes may explain
why alterations in TNF-alpha levels are most likely to be
observed in patients with moderate or severe heart failure.Cardiology Research and Practice 5
4.2. Conclusions. Exercise training reduces levels of TNF-
alpha but not IL-6 in CHF. However, across a heterogenic
patient group, change in peak VO2 was not correlated with
alterations in cytokine levels. While greater exercise volume
(number of hours) was superior in improving peak VO2,n o
particular characteristic of ExT regimes appeared superior in
eﬀecting change in serum cytokines.
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